Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy

Affiliations

Comment

Dustin H Marks et al. JAMA Dermatol. 2020.

. 2020 Dec 1;156(12):1380-1381.

doi: 10.1001/jamadermatol.2020.4380.

No abstract available

Comment in

Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy-Reply.
Thiboutot D, Cartwright M, Mazzetti A. Thiboutot D, et al. JAMA Dermatol. 2020 Dec 1;156(12):1381. doi: 10.1001/jamadermatol.2020.3341. JAMA Dermatol. 2020. PMID: 33146696 No abstract available.

Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
Hebert A, Thiboutot D, Stein Gold L, Cartwright M, Gerloni M, Fragasso E, Mazzetti A. Hebert A, et al. JAMA Dermatol. 2020 Jun 1;156(6):621-630. doi: 10.1001/jamadermatol.2020.0465. JAMA Dermatol. 2020. PMID: 32320027 Free PMC article. Clinical Trial.
A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne.
Barbieri JS. Barbieri JS. JAMA Dermatol. 2020 Jun 1;156(6):619-620. doi: 10.1001/jamadermatol.2020.0464. JAMA Dermatol. 2020. PMID: 32320045 No abstract available.